Live AstraZeneca updates

Live AstraZeneca news coverage of developments with the latest updates. Stay on top of latest AstraZeneca news stories and find out what just happened, what is going on with AstraZeneca. The latest real-time news updates and headlines on AstraZeneca
EU Panel Backs Enhertu for Early HER2+ Breast Cancer
CHMP Backs Klygefa for EU Approval in Treating gMG
Efzimfotase Alfa Gets US Priority Review for HPP Treatment
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer
SERENA-4 Trial: Etcamah, Palbociclib in ER+ Breast Cancer
TGA Product Information Safety Updates 11 September
Prioritize Health Over Weight Loss in Obesity Treatment
Cedars-Sinai Unveils Cancer, Brain, Microbiome Insights
New Therapy Cuts COPD Flare-Ups, Trials Show
Imfinzi Combo Boosts Survival in Small Cell Lung Cancer
Tozorakimab Reduces COPD Exacerbations in Phase III Trials
US Approves Etcamah, CDK4/6 Inhibitor for 1st-Line HR+ Breast Cancer
GLP-1 Use Rising Rapidly in US Young Children with Obesity
Anifrolumab Tied to Lower Infection, Hospitalization in Lupus
Anifrolumab Tied to Lower Infection, Hospitalization Risks
AstraZeneca Finalizes Global License for Zegfrovy
EU Approves Enhertu, Pertuzumab for HER2+ Breast Cancer
Tagrisso, Orpathys Boost PFS in EGFR Lung Cancer
Tezspire Shows Positive Phase III Results in EoE Study
Thymus Protection May Boost Cancer Therapy Results
Enhertu Boosts Survival in HER2 Lung Cancer Trial
Tagrisso, Orpathys Boost Survival in EGFR Lung Cancer
EVOLVE-Lung02 Trial: Volrustomig, Chemo in Lung Cancer
Top Stroke Experts Convene in Brisbane for ANZSO 2026
Johns Hopkins Experts Co-Author New Liver Cancer Guide
Private Sector Responds to Trump's Call to Cut Prices
UK Expands Global Talent Visa for Top Researchers
MSK Unveils Gut Healing Molecular Switch Cancer Exploits
Blood Test Foretells Immunotherapy Success in Lung Cancer
Blood Test Predicts Immunotherapy Benefit Early
Datroway EU-Approved for Metastatic TNBC First-Line Use
Sonesitatug Vedotin Boosts Survival in Advanced Gastric Cancer
Ultomiris Phase III Trial Update in Post-Transplant TMA
CHMP Backs Enhertu, Pertuzumab for HER2+ Breast Cancer
CHMP Backs EU Approval of Trixeo for Asthma Maintenance
EU OKs Etcamah Combo for 1st-Line ER+ Breast Cancer
1 in 3 Americans Miss Cholesterol Goals, 75% Untreated
TGA Product Information Safety Updates 20 July
COVID-19 Booster Plans Ensure Long-Lasting Immunity
AstraZeneca Secures Global License for Zegfrovy Drug
Key Benefits of UK-Switzerland FTA
Global Biotech Leaders Converge at UAB's BAC 2026
CARDIO-TTRansform Phase III Trial Update for Wainua
U of T, McMaster Launch Life Sciences Fund with Genesys
AI Tool Enhances Cancer Immunotherapy Response Prediction
Manchester Links Science to Global Pharma Pathways
Lancet: MRNA Vaccines Safe, Effective, Promising